S. Soverini, A. Gnani, S. Colarossi, et al. Abl kinase domain mutations are infrequent in early-chronic phase chronic myeloid leukemia patients resistant to imatinib [abstract]. Haematologica 2008, 93(Suppl. 1): Abstract 107.

慢性髓细胞白血病对伊马替尼产生耐药性的机制
Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

夏君燕, 朱 平   

世界肿瘤研究Vol.2 No.3, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2012.23003, July 26 2012

伊马替尼和尼洛替尼治疗慢性粒细胞白血病的疗效比较研究
Observation of Imatinib and Nilotinib in the Treatment of Chronic Myeloid Leukemia

王宇瑶, 杨 洁, 李 杰, 王瑞仓, 袁 军, 李 燕, 张晓霞, 郝洪岭   

世界肿瘤研究Vol.9 No.2, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2019.92010, April 9 2019

博舒替尼治疗慢性粒细胞白血病现状
Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia

余艳玲, 余 涛, 余 甜, 万茜茜   

临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131014, January 6 2023

酪氨酸激酶抑制剂在慢性粒细胞白血病的应用及进展
Application and Progress of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia

王慧娟, 李海亮   

临床医学进展Vol.14 No.10, 全文下载: PDF XML DOI:10.12677/acm.2024.14102826, October 29 2024

奥雷巴替尼治疗慢性髓系白血病的研究进展
Research Progress of Olverembatinib in the Treatment of Chronic Myeloid Leukemia

余 甜, 余 涛   

临床医学进展Vol.13 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1381727, August 9 2023

达沙替尼治疗儿童慢性粒细胞白血病的进展分析
Analysis of the Progress of Dasatinib in the Treatment of Chronic Myeloid Leukemia in Children

覃 欢, 于 洁   

临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112918, December 31 2021